Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Company News

Management tracks: Prometheus, Step, Spero, NorthSea, Aristea, MODAG and more

September 6, 2019 11:45 PM UTC

Salix’s Mark McKenna will become CEO of gastroenterology and autoimmune disease company Prometheus Biosciences Inc. (San Diego, Calif.), formerly known as Precision IBD Inc. McKenna was president at Salix Pharmaceuticals Ltd., a subsidiary of Bausch Health Companies Inc. (TSX:BHC; NYSE:BHC). He succeeds co-founder Scott Glenn, who will serve as adviser and remain on the board. The company also said it is planning to raise a series C next quarter followed by an IPO next year.

Autoimmune disease company Step Pharma S.A.S. (Paris, France) hired Andrew Parker as CEO, succeeding founding CEO Geoffroy de Ribains. Parker was EVP and CSO at Zealand Pharma A/S (CSE:ZEAL; NASDAQ:ZEAL)...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article